Additional affiliation(s)
In the published article, there was an error regarding the affiliation for Janna Berg. As well as having affiliation(s) 1,2, she should also have “3. Department of Clinical Medicine, University of Oslo, Oslo, Norway.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
lung cancer, radiotherapy, stereotactic body radiation therapy, radiation pneumonitis, radiation-induced lung injury (RILI), blood biomarkers, t cell, leukocyte subsets
Citation
Berg J, Halvorsen AR, Bengtson M-B, Lindberg M, Halvorsen B, Aukrust P, Helland Å and Ueland T (2022) Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer. Front. Immunol. 13:1051156. doi: 10.3389/fimmu.2022.1051156
Received
22 September 2022
Accepted
23 September 2022
Published
03 October 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Berg, Halvorsen, Bengtson, Lindberg, Halvorsen, Aukrust, Helland and Ueland.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Janna Berg, jannaberg1@gmail.com
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.